|
Form Serial Number: |
DB20190708E00401 |
1.
Date of relevant event: |
30/05/2019 (dd/mm/yyyy)
|
2.
Date when director became aware of the relevant event / interest in the shares (if later): |
28/06/2019 (dd/mm/yyyy)
|
3.
Stock code: |
00001 |
4.
Name of listed corporation: |
CK Hutchison Holdings Limited |
5.
Name of associated corporation of listed corporation: |
Hutchison China MediTech Limited |
6.
Registered office: |
P.O. Box 309, Ugland House, Grand Cayman, KY1-1104, Cayman Islands |
7.
Principal place of business: |
48th Floor, Cheung Kong Center, 2 Queen's Road Central, Hong Kong |
8.
Class of shares in which interested: |
Ordinary |
9.
Number of issued shares in class: |
666,577,450 |
12.
Exchange on which listed: |
London Stock Exchange and Nasdaq Global Select Market |
13.
Name of director (English) as printed on HKID Card/Passport: |
(Surname) |
Shih |
(Other names) |
Edith |
|
|
|
16.
Name of director (Chinese): |
施熙德 |
17.
Chinese Character Code as printed on HKID Card: |
245735561795 |
|
30.
Details of relevant event: |
|
Brief description of relevant event
|
Capacity in which shares were/are held
|
Number of shares bought/sold or involved
|
Currency of transaction |
On Exchange
|
Off Exchange
|
Before relevant event
|
After relevant event
|
Highest price (per share)
|
Average price (per share)
|
Average consideration (per share)
|
Nature of consideration
|
Long position |
1113 | The number of shares in which you are interested has increased because: any other event (you must briefly describe the relevant event in the Supplementary Information box) |
|
|
|
1,080,000 |
|
|
|
|
|
Short position |
|
|
|
|
|
|
|
|
|
|
|
|
31.
Total shares immediately before the relevant event: |
| Total number of shares | Percentage figure (%) |
Long position | 120,000 | 0.18 |
|
|
32.
Total shares immediately after the relevant event: |
| Total number of shares | Percentage figure (%) |
Long position | 1,200,000 | 0.18 |
|
|
33.
Capacity in which interests disclosed in Box 32 are held: |
Capacity code | Number of shares |
| |
|
|
34.
Further information in derivative interests in associated corporation: |
Derivatives code |
Exercise period (dd/mm/yyyy) |
Consideration - if derivatives granted by associated corporation |
Number of shares |
| | Begins | Ends | Currency | Price for grant | Currency | Exercise price | Currency | Price on assignment | |
Long position | 4104 | Listed derivatives - Other (you must describe the category of derivatives in the Supplementary Information box) |
| | | | | | | | | 450,000 |
|
|
35.
Further information in relation to interests of children under 18 and/or spouse: |
Child/Spouse | Name of child/spouse | Number of shares |
| | |
|
|
36.
Further information in relation to interests of corporations controlled by director: |
Name of controlled corporation | Address and place of incorporation | Name of controlling person | % control | Direct interest (Y/N) | Number of shares |
| | | | | |
|
|
37.
Further information in relation to interests held by director jointly with another person: |
Name of joint shareholder | Address | Number of shares |
| | |
|
|
38.
Further information from a trustee, a beneficiary of a trust, or a person who has set up a discretionary trust: |
Names of Trust | Address | Status code | Number of shares |
| | | |
|
|
39.
Supplementary information: |
(Box 30) - Following a share subdivision of Hutchison China MediTech Limited ("Chi-Med") took effect on 30 May 2019 ("Subdivision"), Chi-Med's 1 ordinary share of US$1.00 each was subdivided into 10 ordinary shares of US$0.10 each. (Box 34) - The equity derivatives represent the American Depositary Shares ("ADS") which are traded on the Nasdaq Global Select Market. Following the Subdivision, the ADS ratio increased and the underlying ordinary shares increased from 50,000 to 500,000.
|
40.
Log/Serial Number of the previous form: |
|
Date of filing this Form 3B: |
08/07/2019 (dd/mm/yyyy)
|
|